syndrome rare form lipodystrophy usually first affects head spreads named luis barraquer roviralta spanish physician arthur simons german evidence links etiology condition fully lipodystrophy often associated glomerulonephritis low serum complement levels presence nephritic factor nephritic factor serum immunoglobulin g interacts alternative pathway convertase activate nephritic factor induces lysis adipocytes secrete adipsin product identical complement factor distribution lipoatrophy postulated dictated variable amounts adipsin secreted adipocytes different locationscitation needed human ptrf mutations may cause secondary deficiency caveolins resulting generalized lipodystrophy association muscular dystrophy complement dysfunction may predispose patients bacterial diagnosis disease mainly clinical see diagnostic criteria laboratory workup needed primarily investigate presence associated disorders metabolic autoimmune renal laboratory work associated diseases includescitation needed confirmatory test wholebody mri usually clearly demonstrates extent lipodystrophy mri recommended routine basiscitation needed review published based patients seen respective authors years also literature review cases acquired partial lipodystrophy apl proposed essential diagnostic based review authors experience proposed apl presents gradual onset bilaterally symmetrical loss subcutaneous fat face neck upper extremities thorax abdomen cephalocaudal sequence sparing lower extremities median age onset lipodystrophy seven years several autoimmune diseases particular systemic lupus erythematosus dermatomyositis associated apl prevalence rates diabetes mellitus impaired glucose tolerance respectively around apl patients low complement levels presence polyclonal immunoglobulin nephritic factor patients developed membranoproliferative glomerulonephritis mpgn median years following onset lipodystrophy compared patients without renal disease mpgn earlier age onset lipodystrophy yr vs yr respectively p higher prevalence hypocomplementemia vs respectively p needed adipose stores gluteal regions lower extremities including soles tend either preserved increased particularly among variable fat loss palms loss intramarrow retroorbital fat demonstratedcitation needed general treatment acquired partial lipodystrophy limited cosmetic dietary medical currently effective treatment exists halt progression diet therapy shown value control metabolic problems use small frequent feedings partial substitution mediumchain triglycerides polyunsaturated fats appears beneficialcitation needed plastic surgery implants monolithic silicon rubber correction deficient soft tissue face shown effective false teeth may useful cases cosmetic reasons longterm treatment usually involves therapy kidney endocrine dysfunctioncitation needed data medications apl limited thiazolidinediones used management various types lipodystrophies bind peroxisome proliferatoractivator receptor gamma ppargamma stimulates transcription genes responsible growth differentiation adipocytes single report suggested beneficial effect treatment rosiglitazone fat distribution acquired partial lipodystrophy however preferential fat gain lower bodycitation needed direct drug therapy administered according associated condition membranoproliferative glomerulonephritis presence renal dysfunction largely determine prognosis acquired partial lipodystrophy standard guidelines management renal disease followed course membranoproliferative glomerulonephritis acquired partial lipodystrophy significantly altered treatment corticosteroids cytotoxic medications recurrent bacterial infections severe might managed prophylactic antibioticscitation needed estimating mortality rate based available literature several case reports revealed association acquired partial lipodystrophy diseasescitation needed nephropathy form membranoproliferative glomerulonephritis occurs patients usually patients clinically evident renal disease abnormalities renal function disease years membranoproliferative glomerulonephritis usually presents asymptomatic proteinuria hematuriacitation needed disease may gradually progress patients develop endstage renal disease course years condition responsible recurrent hospital admissions patients acquired partial lipodystrophy rapid progression renal disease pregnant patient reported recurrent disease transplanted kidneys common although reports successful transplantationscitation needed associated autoimmune diseases eg systemic lupus erythematosus thyroiditis contribute significantly increased morbidity patients compared general population although uncommon insulin resistance increases cardiovascular risk susceptibility bacterial infections probably results deficiency due complement activation consumption low levels may impair complementmediated phagocytosis bacterial killingcitation needed around cases reported since recognition rare syndrome known prevalence although common generalized form acquired lipodystrophy lawrence syndromecitation needed ankyrin long qt syndrome httpsenwikipediaorgwikiprogressivelipodystrophy